Ovarian Cancer - Multiple Locations in the US (Clinical Trial 47143)

This clinical trial is not currently recruiting participants. To find active clinical trials similar to this one please visit Clinical Trials Search. To be notified of new clinical trials as they become available visit Free Member Signup.

Study summary

The AXLerate-OC Study: A Research Study Evaluating the Effect of a New Drug in Subjects with Platinum-Resistant Recurrent Ovarian Cancer.

Why is the AXLerate-OC Study being done?

The AXLerate-OC Study is evaluating the effect of a new drug on survival in subjects with platinum-resistant recurrent ovarian cancer.

Is the AXLerate-OC Study an option for you? You may be able to participate in the AXLerate-OC Study if all of the following criteria are met:

You are at least 18 years of age.
You have been diagnosed with recurrent ovarian, fallopian tube, or peritoneal cancer.
You have platinum-resistant disease (meaning cancer has returned within 6 months of last platinum-containing treatment or therapy)
You have received at least 1, but not more than 4, prior treatment regimens since your ovarian cancer diagnosis.

There are other eligibility requirements that the study evaluator will review with you.

For more information about the AXLerate-OC Study and to see if you may qualify to participate, please CLICK HERE

Study is available at

This study is being conducted NATIONWIDE! To find clinics conducting this study near you please use search feature below.

Study Locations

ClinicalConnection.com is a resource that provides information on clinical trials and other research opportunities worldwide.

ClinicalConnection.com does not conduct or endorse this research. Please consult your physician before participating.

Latest Blog Posts

Useful Links

Contact Us

75 Second Ave, Suite 605
Needham, MA 02494
1-800-887-0639
info@clinicalconnection.com
Click here to contact us

Services for Research Sites

National Recruitment Services

News And Information